Health·August 6, 2026·2 min read

FDA Clears Four New on! Nicotine Pouches

Health groups warn of youth appeal after latest authorization

Logo of the U.S. Food and Drug Administration (FDA).
File photoLogo of the U.S. Food and Drug Administration (FDA).U.S. Food and Drug Administration

The U.S. Food and Drug Administration authorized four new flavored oral nicotine pouch products on August 4, 2026, allowing them to be legally marketed in the United States. The products are sold under the on! brand by Helix Innovations LLC, a subsidiary of Altria Group. FDA officials said the products met the legal standard for marketing but emphasized that no tobacco product is considered safe and that people who do not already use nicotine should not begin.

The latest action expands the growing number of FDA-authorized nicotine pouch products following earlier approvals for ZYN and other on! products over the past year. Unlike the FDA's previous Modified Risk Tobacco Product authorization for certain ZYN products, the new marketing orders allow the products to be sold but do not permit companies to claim they reduce health risks compared with cigarettes unless separately authorized.

Public health organizations expressed concern that additional flavored nicotine pouches could increase youth interest in nicotine products. The American Heart Association says oral nicotine pouches have become the second most commonly used tobacco product among U.S. middle and high school students and has warned that flavors such as fruit, dessert, and spice may make the products more appealing to younger users. The Campaign for Tobacco-Free Kids has also urged the FDA to closely monitor youth usage and revoke marketing orders if evidence shows increasing underage use.

Under the Family Smoking Prevention and Tobacco Control Act, the FDA may authorize tobacco products for sale if they are determined to be appropriate for the protection of public health after weighing potential benefits for adult smokers against risks to nonusers and youth. The agency said it will continue monitoring the newly authorized products and can withdraw its authorization if post-market evidence no longer supports their continued sale.

Community discussion
"Do you think FDA authorization changes how consumers perceive the risks of nicotine pouch products compared with traditional cigarettes?"